Recent Advances in Small-Molecule-Based Nanovectors for the Treatment of Colorectal Cancer
Open Access
Abstract
Colorectal cancer (CRC) remains a major global health burden, while conventional systemic therapies are limited by toxicity, drug resistance, suboptimal tumour exposure, and pharmacokinetic constraints. Recent advances in nanotechnology have produced diverse nanosystems including liposomes, dendrimers, polymeric nanoparticles, metallic nanoparticles, mesoporous silica systems, and other hybrid platforms that can improve drug solubility, stability, biodistribution, controlled release, and tumour-directed delivery. Plant-derived small molecules provide an additional source of structurally diverse anticancer candidates, but their clinical development is often constrained by poor aqueous solubility, rapid metabolism, limited bioavailability, and non-specific toxicity. This review critically examines recent progress in nanoscale delivery systems for CRC and evaluates their potential for delivering plant-derived and other bioactive small molecules. Particular emphasis is placed on passive and active targeting, physicochemical determinants of delivery, platform-specific advantages and limitations, preclinical evidence, and the barriers to clinical translation. The review also highlights the distinction between plant-derived and fungal-derived natural products and identifies opportunities for integrating natural products with responsive and ligand-functionalized nanocarriers.Keywords
Funding Information
- National Research Foundation (CSRP200429517876)
This publication has 165 references indexed in Scilit:
- Nanozymes for Liver Disease Therapy: Advances in Catalytic Activity, Targeting Strategies, and Clinical TranslationAdvanced Science, 2026
- A Mitochondria‐Specific Nanomedicine for Synergistic Chemo‐Photothermal Therapy and Immunogenic Activation Against Breast CancerAdvanced Science, 2026
- Macrophage‐Anchored Nanofibers with Supramolecular Phenolic Gates for pH‐Responsive ChemotherapyAdvanced Healthcare Materials, 2025
- Comprehensive Review—Chemistry and Bioactivities of Secondary Metabolites From Chaetomium globosumChemistry & Biodiversity, 2025
- Advancements in Targeted Therapies for Colorectal Cancer: Innovative Drug Formulation and Delivery StrategiesArchiv der Pharmazie, 2025
- Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological ApplicationsAdvanced Healthcare Materials, 2024
- Integrating natural compounds and nanoparticle‐based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapyCancer Medicine, 2024
- Ligand conjugated lipid‐based nanocarriers for cancer theranosticsBiotechnology and Bioengineering, 2022
- PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug DeliveryAdvanced Healthcare Materials, 2022
- PEGylated Nanoparticles as a Versatile Drug Delivery System2021